8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001140361-24-048749
CIK 0001479290operating
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 9:17 AM ET
Size
1.5 MB
Accession
0001140361-24-048749
Documents
- 8-Kef20039500_8k.htmPrimary
8-K
- EX-2.1ef20039500_ex2-1.htm
EXHIBIT 2.1
- EX-10.1ef20039500_ex10-1.htm
EXHIBIT 10.1
- EX-99.1ef20039500_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHrvnc-20241207.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABrvnc-20241207_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PRErvnc-20241207_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICcrown-logo.jpg
- GRAPHICrevance-logo.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001140361-24-048749-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLef20039500_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 9:17 AM ET
- Size
- 1.5 MB